Top

Cancer Causes & Control

Published in:

01-12-2004

Prospective study of plasma enterolactone and prostate cancer risk (Sweden)

Authors: Pär Stattin, Annika Bylund, Carine Biessy, Rudolf Kaaks, Göran Hallmans, Herman Adlercreutz

Published in: Cancer Causes & Control | Issue 10/2004

Title: Prospective study of plasma enterolactone and prostate cancer risk (Sweden)
Authors: Pär Stattin
Annika Bylund
Carine Biessy
Rudolf Kaaks
Göran Hallmans
Herman Adlercreutz
Publication date: 01-12-2004
Publisher: Kluwer Academic Publishers
Published in: Cancer Causes & Control / Issue 10/2004
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-004-1480-7

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 10/2004

Rationale and design of the National Program of Cancer Registries' breast, colon, and prostate cancer patterns of care study

A case–control study of occupational risk factors for bladder cancer in Canada

Maternal smoking during pregnancy and risk of brain tumors in the offspring. A prospective study of 1.4 million Swedish births

Author index to Volume 15

key word index to Volume 15

List of reviewers for Volume 15

Keynote webinar | Spotlight on antibody–drug conjugates in cancer